mRNA nanodelivery systems: targeting strategies and administration routes

被引:23
|
作者
Yuan, Mujie [1 ]
Han, Zeyu [1 ]
Liang, Yan [2 ]
Sun, Yong [2 ]
He, Bin [3 ]
Chen, Wantao [4 ]
Li, Fan [1 ]
机构
[1] Qingdao Univ, Affiliated Hosp, Dept Oral Implantol, Qingdao 266000, Peoples R China
[2] Qingdao Univ, Sch Pharm, Dept Pharmaceut, Qingdao 266073, Peoples R China
[3] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China
[4] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Oral & Maxillofacial Head & Neck Oncol, Shanghai 200011, Peoples R China
基金
美国国家科学基金会;
关键词
mRNA; Nanodelivery systems; Targeting; Administration routes; NUCLEIC-ACID DELIVERY; LIPID NANOPARTICLES; IN-VIVO; DENDRITIC CELLS; PHYSICOCHEMICAL PROPERTIES; POLYMERIC NANOPARTICLES; BIOLOGICAL BARRIERS; DRUG-DELIVERY; PROTEIN; VACCINE;
D O I
10.1186/s40824-023-00425-3
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
With the great success of coronavirus disease (COVID-19) messenger ribonucleic acid (mRNA) vaccines, mRNA therapeutics have gained significant momentum for the prevention and treatment of various refractory diseases. To function efficiently in vivo and overcome clinical limitations, mRNA demands safe and stable vectors and a reasonable administration route, bypassing multiple biological barriers and achieving organ-specific targeted delivery of mRNA. Nanoparticle (NP)-based delivery systems representing leading vector approaches ensure the successful intracellular delivery of mRNA to the target organ. In this review, chemical modifications of mRNA and various types of advanced mRNA NPs, including lipid NPs and polymers are summarized. The importance of passive targeting, especially endogenous targeting, and active targeting in mRNA nano-delivery is emphasized, and different cellular endocytic mechanisms are discussed. Most importantly, based on the above content and the physiological structure characteristics of various organs in vivo, the design strategies of mRNA NPs targeting different organs and cells are classified and discussed. Furthermore, the influence of administration routes on targeting design is highlighted. Finally, an outlook on the remaining challenges and future development toward mRNA targeted therapies and precision medicine is provided.
引用
收藏
页数:48
相关论文
共 50 条
  • [11] Formulation Strategies of Nanosuspensions for Various Administration Routes
    Pinar, Sila Gulbag
    Oktay, Ayse Nur
    Karakucuk, Alptug Eren
    Celebi, Nevin
    PHARMACEUTICS, 2023, 15 (05)
  • [12] Nanodelivery Systems Targeting Epidermal Growth Factor Receptors for Glioma Management
    Paranthaman, Sathishbabu
    Goravinahalli Shivananjegowda, Meghana
    Mahadev, Manohar
    Moin, Afrasim
    Hagalavadi Nanjappa, Shivakumar
    Nanjaiyah, Nandakumar Dalavaikodihalli
    Chidambaram, Saravana Babu
    Gowda, Devegowda Vishakante
    PHARMACEUTICS, 2020, 12 (12) : 1 - 29
  • [13] Preparation of nanodelivery systems for oral administration of low molecular weight heparin
    Ozemre, Gamze Ruzgar
    Kara, Adnan Altug
    Pezik, Esra
    Tort, Serdar
    Vural, Imran
    Acarturk, Fusun
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2023, 79
  • [14] Recent Advances in the Development of Nanodelivery Systems Targeting the TRAIL Death Receptor Pathway
    Yagolovich, Anne V.
    Gasparian, Marine E.
    Dolgikh, Dmitry A.
    PHARMACEUTICS, 2023, 15 (02)
  • [15] Tumor-targeting nanodelivery systems: Expanding the potential for cancer therapy and diagnosis
    Chang, EH
    ONCOLOGY RESEARCH, 2006, 15 (10-12) : 463 - 463
  • [16] Shortcut Approaches to Substance Delivery into the Brain Based on Intranasal Administration Using Nanodelivery Strategies for Insulin
    Tashima, Toshihiko
    MOLECULES, 2020, 25 (21):
  • [17] Advances in Nanodelivery Systems Based on Metabolism Reprogramming Strategies for Enhanced Tumor Therapy
    Zhang, Zongquan
    Liang, Xiaoya
    Yang, Xi
    Liu, Yan
    Zhou, Xiangyu
    Li, Chunhong
    ACS APPLIED MATERIALS & INTERFACES, 2024, 16 (06) : 6689 - 6708
  • [18] Advances in Nanodelivery Systems Based on Metabolism Reprogramming Strategies for Enhanced Tumor Therapy
    Department of Pharmaceutical Sciences, School of Pharmacy, Southwest Medical University, Sichuan, Luzhou
    646000, China
    不详
    646000, China
    不详
    646000, China
    ACS Appl. Mater. Interfaces, 6 (6689-6708): : 6689 - 6708
  • [19] New strategies in insulin treatment: analogues and noninvasive routes of administration
    Rungby, J
    Brock, B
    Schmitz, O
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2005, 19 (02) : 127 - 132
  • [20] Tumor-targeting nanodelivery systems: Expanding the potential for cancer therapy and diagnosis.
    Chang, EH
    Rait, A
    Pirollo, KF
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9173S - 9173S